Location: DIBIT1 A3, Floor 1, Room 11
Deputy director, Diabetes Research Institute
Head, Immune-mediated diseases Unit
Upon obtainig her degree in Biology in Milan, Manuela Battaglia got her PhD in Molecular Medicine in the United States – at the Wisconsin Medical College – where she learned how to do research and developed expertise into preclinical models of transplantation (she then got a PhD in Immunology at the University of Utrecht, Netherlands, in 2014).
After earning her doctorate, she returned to Italy to work at San Raffaele Telethon Institute for Gene Therapy in Ospedale San Raffaele, where she began her career focused on immune-mediated diseases and induction of immune tolerance after gene therapy. At 2008 she joined the recently born San Raffaele Diabetes Research Institute (DRI) where – first Head of Unit and, from 2013, also as Vice-Director – she focused her scientific interest on understanding the origin and the pathogenic mechanisms underlying immune-mediated diseases, in particular the diabetes type 1.
Currently Manuela Battaglia is conducting an experimental project of cell therapy to induce immune tolerance after solid organ transplantation to prevent the use of immunosuppressive drugs. Manuela Battaglia is also one of the Board members of TrialNet (an international network of researchers – founded by NIH – focused on understanding, prevention and treatment of type 1 diabetes).
Dr. Battaglia is the author of more than 90 original articles published in international peer-reviewed journals and she is among the most cited Italian researchers in the field of immunological tolerance.
She has been a member of the Scientific Committee of the European Society for Organ Transplantation (ESOT). She is currently palying key roles in many international scientific journals and serves as a scientific reviewer for several international funding agencies. She is also the inventor of several patents.